Great to catch American Society of Nephrology President-Elect Prabir Roy Chaudhury presenting on ASN's new NIDDK funded program, 'Fostering Inclusivity in Dialysis Access (FinD)' today NIH

Should polypharmacy dissuade treatment optimization in heart failure?

No.

Hot off the press data suggest efficacy is sustained (maybe even better!) among those on a large # of background medicines.

#ARNI in #PARAGONHF (L) & #SGLT2i in #DELIVER (R)

👇🏾

Nice review on kidney injury biomarkers for the evaluation of CKDu by Sophie Claudel, MD

Systematic Review of #KidneyInjury #Biomarkers for the Evaluation of Chronic Kidney Disease of Uncertain #CKDu Etiology

#VisualAbstract by Renz Michael Pasilan

kireports.org/article/S2468-…

New study in Annals reveals higher albuminuria levels in CKD patients with normoalbuminuria correlate with increased risk of progression: ow.ly/B6yr50R6ET1 Ashish Verma BU/BMC Section of Nephrology UIC Nephrology Boston U Chobanian & Avedisian School of Medicine

acpjournals.org/doi/10.7326/M2… Congratulations to Drs. Ashish Verma, Sushrut Waikar, Insa Schimdt, Sophie Claudel and all other authors on the publishing of their article

New study in Annals reveals higher albuminuria levels in CKD patients with normoalbuminuria correlate with increased risk of progression: ow.ly/B6yr50R6ET1 Ashish Verma BU/BMC Section of Nephrology UIC Nephrology Boston U Chobanian & Avedisian School of Medicine

CKD Progress Risk Increased Even if Albuminuria Range Normal medscape.com/viewarticle/ck… medscape.com/viewarticle/ck…

New study from BU’s Dr. Ashish Verma will help physicians to identify patients at risk for kidney disease progression at very early level of their natural history of disease. To learn more, click here: healthday.com/healthpro-news…

Read our paper on “ Prognostic significance of low levels of albuminuria with respect to CKD progression and ESKD in persons with mildly increased albuminuria (< 30 mg/g)”. The absolute risk difference between persons with UACR > 15 mg/g and < 5 mg/g is 10.7 %.

📣📣Nephrologists, Hematologists, Pathologists📣📣
A survey (3-5min) on kidney transplant candidacy for plasma cell dyscrasia (myeloma, amyloidosis, MGRS). What criteria would you use?
redcap.link/PCD_kidney_tx
Thank you for your input!! 🙏🙏 Kidney Pancreas Community of Practice - AST

Thank you ASN Kidney360 for providing an opportunity to delve deep into SGLT2i’s role on TGF and its favorable impact on energy utilization/delivery, cellular homeostasis/autophagy, sympathetic tone, and vascular health/microvascular function.@ASNKidney National Kidney Foundation BU/BMC Section of Nephrology

➡️ Biomarker Blues: Balancing Hope and Hype in Acute Kidney Injury kidney-international.org/article/S0085-…

Preprint of our work examining the effects of 7 different #SDOH in adults without major chronic diseases. Ashish Verma

🖥️ Join our #KidneyActionWeek session, Heart Health and Kidney Disease: What’s The Connection? on Mon. March 18 at 11AM EST learn more about the connection, identify risk factors for CKM syndrome and hear tips for how to talk to your doctor. Register: bit.ly/42QM6Fj

Comprehensive review on ATTR cardiac amyloidosis by Dr. Ruberg of BU Amyloidosis Center.

jamanetwork.com/journals/jama/…

Celebrating the achievements of two extraordinary nephrologists ⁦tonight at ⁦NKF- New England⁩ Honors ⁦Sushrut Waikar⁩ #KevinTucker ⁦NKF Nephrology Professionals⁩

Systemic Amyloidosis and Kidney Transplantation: An Update pubmed.ncbi.nlm.nih.gov/38490903/
BU Amyloidosis Center Ashish Verma